Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Copytele Inc    COPY

SummaryNewsCompany 
News SummaryMost relevantAll newsSector news 

Copytele Inc : CopyTele Enters into License Agreement with Elixir Industries

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/22/2013 | 04:37pm CEST

MELVILLE, NY - October 22, 2013: CopyTele, Inc. ("CTI") (OTCQB: COPY), a company specializing in patent monetization and patent assertion, today announced that its wholly owned subsidiary, J-Channel Industries Corporation, has entered into a license agreement with Elixir Industries, in connection with CTI's patented J-Channel Window Frame Construction technology.

The license is the third license for the J-Channel Window Frame Construction technology, and resolves the patent infringement lawsuit filed against Elixir Industries and Clayton Homes, Inc., on August 7, 2013, which will be dismissed.

On October 10, 2013, the company announced the filing of 19 additional lawsuits in connection with its patented J-Channel Window Frame Construction technology. Estimates indicate that more than 10 million J-Channel windows are sold in the U.S. each year.

In total, CTI and its subsidiary companies currently have 38 active lawsuits across 5 patented technologies including E-Paper Electrophoretic Displays, Nano Field Emission Displays, Key Based Web Conferencing Encryption, J-Channel Window Frame Construction, and Loyalty Conversion Systems.

About CopyTele, Inc.

CTI develops and acquires patented technologies for the purposes of patent monetization and patent assertion. The company currently has 6 patent portfolios in the areas of Key Based Web Conferencing Encryption, E-Paper® Electrophoretic Displays, Nano Field Emission Displays, Micro Electro Mechanical Systems Displays, Loyalty Conversion Systems, and J-Channel Window Frame Construction.  Additional information is available at www.CTIpatents.com.

# # #

Forward-Looking Statements:

Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect CopyTele's current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements.  Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements.  These risks, uncertainties and factors include, but are not limited to, those factors set forth in "Item 1A - Risk Factors" and other sections of our Annual Report on Form 10-K for the fiscal year ended October 31, 2012 as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.  We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.  You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release.

Contact:
Ron Tenio
631-549-5900
rtenio@CTIpatents.com

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on COPYTELE INC
08/26 ITUS CORP : Submission of Matters to a Vote of Security Holders, Notice of Delis..
08/19 ITUS : Management's Discussion and Analysis of Financial Condition and Results o..
08/15 ITUS : Extends and Expands Collaborative Research Arrangement With The Wistar In..
07/05 ITUS : Virtua Healthcare System Joins ITUS Early Cancer Detection Biomarker Stud..
05/31 ITUS : to Ring June 3, 2016 Nasdaq Closing Bell and Launch New Cancer Social Med..
05/20 ITUS : Management's Discussion and Analysis of Financial Condition and Results o..
04/28 ITUS : Featured on New York Radio Program
04/25 ITUS : Featured on FOX News Health Segment
04/19 ITUS : Subsidiary Anixa Diagnostics Corporation Demonstrates Efficacy of Early C..
04/14 ITUS : Featured on Several National and Local Radio Broadcasts
More news
Sector news : Business Support Services - NEC
08/26 WORLDPAY : Payments company Nets to set listing plan in motion next week
08/22 Syngenta surge sees Swiss stocks outperform Europe
08/18DJSamsung Shares Hit Record
08/16DJSome Firms Intensify Push for Gender Parity at Board Level
08/16DJCitigroup Taps J.P. Morgan Executive for Technology Role
More sector news : Business Support Services - NEC
Advertisement
Managers
NameTitle
Robert Andrew Berman President, Chief Executive Officer & Director
Lewis H. Titterton Chairman
Dean Krouch Secretary & Operations Director
Henry P. Herms Chief Financial Officer & Vice President-Finance
Bruce F. Johnson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
COPYTELE INC0
VISA INC3.89%190 210
ACCENTURE PLC10.24%74 958
ECOLAB INC.7.48%35 846
CINTAS CORPORATION27.08%12 058
ALLIANCE DATA SYSTEMS ..-28.17%11 627
More Results